Nutrigenomics - 2006 Update

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 3, 2007, Pages 279-287

  Kaput, Jim ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NuGO ^*  (United States)

Author keywords

Epistasis; Gene nutrient interactions; Genetics; Nutrigenomics; Nutrition

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; GLUCAGON LIKE PEPTIDE 1; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA;

CARDIOVASCULAR DISEASE; CHROMOSOME ANALYSIS; CONFERENCE PAPER; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DRUG TARGETING; FOOD INDUSTRY; GENE INTERACTION; GENETIC ANALYSIS; GENETIC CORRELATION; GENETIC DISORDER; GLUCONEOGENESIS; GLUCOSE ABSORPTION; HUMAN; HUMAN GENOME; INSULIN RELEASE; INSULIN SENSITIVITY; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIGENOMICS; NUTRITIONAL ASSESSMENT; OBESITY; PHENOTYPIC PLASTICITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

GENOMICS; HUMAN GENOME PROJECT; HUMANS; NUTRITION ASSESSMENT; VARIATION (GENETICS);

EID: 33947579534     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.057     Document Type: Conference Paper

References (55)

1. Kaput J, Ordovas JM, Ferguson L, van Ommen B, Rodriguez RL, Allen L, et al. The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 2005;94:623-32.
2. Jorde LB, Wooding SP. Genetic variation, classification and "race". Nat Genet 2004;36(Suppl 1):S28-33.
3. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-9.
4. Hartman JL, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science 2001;291:1001-4.
5. Carlborg O, Haley CS. Epistasis: too often neglected in complex trait studies? Nat Rev Genet 2004;5:618-25.
6. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003;56:73-82.
7. Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004;16:166-77.
8. van Ommen B, Stierum R. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol 2002;13:517-21.
9. Ordovas JM. The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins. Proc Nutr Soc 2004;63:145-52.
10. Corella D, Ordovas JM. The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis. Curr Atheroscler Rep 2004;6:186-96.
11. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 2006;38:68-74.
12. Campbell CD, Ogburn EL, Lunetta KL, Lyon HN, Freedman ML, Groop LC, et al. Demonstrating stratification in a European American population. Nat Genet 2005;37:868-72.
13. Helgason A, Yngvadottir B, Hrafnkelsson B, Gulcher J, Stefansson K. An Icelandic example of the impact of population structure on association studies. Nat Genet 2005;37:90-5.
14. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999;18:4608-18.
15. Naciff JM, Jump ML, Torontali SM, Carr GJ, Tiesman JP, Overmann GJ, et al. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 2002;68:184-99.
16. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000;97:7500-2.
17. Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, et al. 2.1 Å crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 2003;42:1430-8.
18. Tirona RG, Leake BF, Podust LM, Kim RB. Identification of amino acids in rat pregnane X receptor that determine species-specific activation. Mol Pharmacol 2004;65:36-44.
19. Rebbeck TR, Spitz M, Wu X. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 2004;5:589-97.
20. Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res 2002;10:518-25.
21. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803-12.
22. Nosjean O, Boutin JA. Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? Cell Signal 2002;14:573-83.
23. Guo S, Sonenshein G. Green tea polyphenols and cancer prevention. In: Kaput J, Rodriguez RL, editors. Nutritional genomics. Discovering the path to personalized nutrition. Hoboken, NJ: John Wiley and Sons, 2006:177-206.
24. Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol 2003;65:261-311.
25. Gillies PJ. Nutrigenomics: the Rubicon of molecular nutrition. J Am Diet Assoc 2003;103:S50-5.
26. Jacobs MN, Lewis DF. Steroid hormone receptors and dietary ligands: a selected review. Proc Nutr Soc 2002;61:105-22.
27. Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res 2004;551:51-64.
28. Simopoulos AP, Ordovas JM, editors. Nutrigenetics and nutrigenomics. World Rev Nutr Diet 2004;93:1-324.
29. Schuster GU. Nutrients and gene expression. In: Kaput J, Rodriguez RL, editors. Nutritional genomics. Discovering the path to personalized nutrition. Hoboken, NJ: John Wiley and Sons, 2006:153-76.
30. Kaput J, Rodriguez, RL, editors. Nutritional genomics. Discovering the path to personalized nutrition. Hoboken, NJ: John Wiley and Sons, 2006:469.
31. Netting AG. pH, abscisic acid and the integration of metabolism in plants under stressed and non-stressed conditions. II. Modifications in modes of metabolism induced by variation in the tension on the water column and by stress. J Exp Bot 2002;53:151-73.
32. Malfatti MA, Felton JS. Susceptibility to exposure to heterocyclic amines from cooked food: role of UDP-glucuronosyltransferases. In: Kaput J, Rodriguez RL, editors. Nutritional genomics. Discovering the path to personalized nutrition. Hoboken, NJ: John Wiley and Sons, 2006:331-52.
33. Dennis LK, Snetselaar LG, Nothwehr FK, Stewart RE. Developing a scoring method for evaluating dietary methodology in reviews of epidemiologic studies. J Am Diet Assoc 2003;103:483-7.
34. Yon BA, Johnson RK, Harvey-Berino J, Gold BC. The use of a personal digital assistant for dietary self-monitoring does not improve the validity of self-reports of energy intake. J Am Diet Assoc 2006;106:1256-9.
35. Lillegaard IT, Andersen LF. Validation of a pre-coded food diary with energy expenditure, comparison of under-reporters v. acceptable reporters. Br J Nutr 2005;94:998-1003.
36. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997;278:1580-1.
37. Lander ES. The new genomics: global views of biology. Science 1996;274:536-9.
38. Muller M, Kersten S. Opinion: Nutrigenomics: goals and strategies. Nat Rev Genet 2003;4:315-22.
39. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet 2004;5:71-118.
40. Bishop JM. Cellular oncogenes and retroviruses. Annu Rev Biochem 1983;52:301-54.
41. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003;33(Suppl):238-44.
42. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27:17-20.
43. Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 2004;53(Suppl 3):S225-32.
44. Nauck MA, Meier JJ. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul Pept 2005;128:135-48.
45. Kaput J, Swartz D, Paisley E, Mangian H, Daniel WL, Visek WJ. Diet-disease interactions at the molecular level: an experimental paradigm. J Nutr 1994;124:1296S-305S.
46. Kaput J, Astley S, Renkema M, Ordovas J, van Ommen B. Harnessing nutrigenomics: development of web-based communication, databases, resources, and tools. Genes Nutr 2006;1:5-12.
47. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001;291:1304-51.
48. The human genome. Science genome map. Science 2001;291:1218.
49. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
50. International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nat Rev Genet 2004;5:467-75.
51. International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
52. Garosi P, De Filippo C, van Erk M, Rocca-Serra P, Sansone SA, Elliott R. Defining best practice for microarray analyses in nutrigenomic studies. Br J Nutr 2005;93:425-32.
53. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr 2005;82:497-503.
54. Fuchs D, Winkelmann I, Johnson IT, Mariman E, Wenzel U, Daniel H. Proteomics in nutrition research: principles, technologies and applications. Br J Nutr 2005;94:302-14.
55. Ottman R. Gene-environment interaction: definitions and study designs. Prev Med 1996;25:764-70.